May 2024

While COL11A1 was one of the 156 targets identified that the researchers validated in mouse models, others showed promise in cell lines such as anti-fibronectin CAR T cells. Most targets have yet to be tested but are publicly available for other researchers to pursue.

Acute lymphoblastic leukemia (ALL) is the most common childhood cancer. Survival rates are over 94% due to modern therapy. However, those with relapsed or recurrent disease, often due to chemotherapy resistance, have a much poorer 30-40% survival rate.

M.Sc / M.Pharm. in Organic Chemistry / Analytical Chemistry / Natural Products Chemistry / Pharmaceutical Chemistry / Biochemistry. Experience in extraction, isolation, and characterization of secondary metabolites from natural sources from plants, microbial cultures, and marine invertebrates; the uses of modern analytical and spectroscopic techniques and knowledge of phyto-pharmaceutical drug discovery; proficiency in reviewing relevant literature and compiling detailed reports.

significant experience in animal handling, Pharmacological drug screening using in vitro and in vivo models, neuroscience, histopathological techniques, and molecular biology methodologies are preferred.  Proficiency in any or all of the following areas is advantageous: small animal surgeries like MCAO, neuronal cell culture, invitro Oxygen-Glucose Deprivation OGD model, Fluorescence-Activated Cell Sorting, immunofluorescence techniques including double/triple immunolabeling, confocal microscopy, Chromatin Immunoprecipitation CHIP, and Polymerase Chain Reaction (PCR) techniques.

Graduate in Biochemistry/ Biotechnology/ Life Science from recognized university plus three years experience OR PG in relevant subject/field from recognized university/institute. Knowledge of Regulatory guidelines ISO, Drug and Cosmetic Act 1945, and Medical Device Rules 2017

graduation in life sciences Molecular biology/ Biotechnology/ Microbiology/ Virology/ any other subjects related to health Or Postgraduate in relevant subject. Development of a graphical user interface GUI based simulation platform for the dynamics study of the human heart under normal and abnormal condition

A randomized, open-Iabel, controlled clinical trial to decipher the role of chrono pharmacokinetics and chrono genomics of tyrosine kinase inhibitors in the treatment of non-small cell lung cancer patients.

Conduct comprehensive market research to discern trends, competitors, and growth opportunities within the European pharmaceutical sector. Execute strategic business plans tailored to augment our footprint in the Formulation segments, in alignment with organizational objectives.